Schrodinger Inc
SDGR19.943USD
+0.413+2.11%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
1.46BCap. mercado
PérdidaP/E TTM
Más Datos de Schrodinger Inc Compañía
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.
Información de la empresa
Símbolo de cotizaciónSDGR
Nombre de la empresaSchrodinger Inc
Fecha de salida a bolsaFeb 06, 2020
Director ejecutivoDr. Ramy Farid, Ph.D.
Número de empleados891
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 06
Dirección1540 Broadway
CiudadNEW YORK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal10036
Teléfono15032991150
Sitio Webhttps://www.schrodinger.com
Símbolo de cotizaciónSDGR
Fecha de salida a bolsaFeb 06, 2020
Director ejecutivoDr. Ramy Farid, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
Michael M. Lynton ,
Michael M. Lynton ,
Independent Chairman of the Board
Independent Chairman of the Board
12.25K
+95.95%
Ms. Bridget Anne Van Kralingen
Ms. Bridget Anne Van Kralingen
Independent Director
Independent Director
11.50K
+14.99%
Mannix Aklian
Mannix Aklian
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
--
--
Mr. Gary Ginsberg, J.D.
Mr. Gary Ginsberg, J.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
Other
2.38M
4.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
29.66M
49.81%
EMEA
23.08M
38.76%
APAC
6.07M
10.20%
Rest of World
731.00K
1.23%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
Other
2.38M
4.00%
Estadísticas de accionistas
Actualizado: vie., 23 de may
Actualizado: vie., 23 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.07%
Bill & Melinda Gates Foundation Trust
10.87%
The Vanguard Group, Inc.
10.17%
Rubric Capital Management LP
7.48%
Nikko Asset Management Co., Ltd.
5.68%
Other
53.73%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.07%
Bill & Melinda Gates Foundation Trust
10.87%
The Vanguard Group, Inc.
10.17%
Rubric Capital Management LP
7.48%
Nikko Asset Management Co., Ltd.
5.68%
Other
53.73%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.38%
Investment Advisor/Hedge Fund
25.00%
Hedge Fund
13.63%
Endowment Fund
10.87%
Individual Investor
2.65%
Research Firm
2.22%
Pension Fund
0.80%
Bank and Trust
0.49%
Venture Capital
0.13%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
570
67.20M
104.65%
-5.08M
2025Q1
593
67.21M
104.69%
-5.43M
2024Q4
576
64.44M
100.89%
-9.04M
2024Q3
581
67.44M
105.91%
-6.15M
2024Q2
573
64.76M
101.80%
-8.12M
2024Q1
574
63.48M
100.05%
-5.40M
2023Q4
584
62.06M
98.56%
-7.64M
2023Q3
586
63.62M
101.35%
-15.42M
2023Q2
584
64.04M
102.20%
-7.30M
2023Q1
543
57.09M
91.59%
-11.19M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
7.75M
12.07%
-354.21K
-4.37%
Mar 31, 2025
Bill & Melinda Gates Foundation Trust
6.98M
10.87%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
6.53M
10.17%
-72.09K
-1.09%
Mar 31, 2025
Rubric Capital Management LP
4.80M
7.48%
-200.00K
-4.00%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
3.46M
5.39%
-48.10K
-1.37%
Mar 31, 2025
UBS Asset Management (Switzerland)
2.47M
3.85%
+919.38K
+59.31%
Mar 31, 2025
Stephens Investment Management Group, LLC
1.97M
3.07%
+362.29K
+22.53%
Mar 31, 2025
State Street Global Advisors (US)
2.21M
3.44%
-104.66K
-4.52%
Mar 31, 2025
MFS Investment Management
2.09M
3.26%
-186.23K
-8.17%
Mar 31, 2025
ARK Investment Management LLC
2.29M
3.57%
+85.76K
+3.88%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Genomic Revolution ETF
3.78%
TrueShares Technology, AI & Deep Learning ETF
2.24%
Global X HealthTech ETF
1.25%
SPDR FactSet Innovative Technology ETF
0.97%
WisdomTree BioRevolution Fund
0.84%
Franklin Exponential Data ETF
0.81%
Invesco S&P SmallCap Health Care ETF
0.8%
Franklin Genomic Advancements ETF
0.63%
First Trust Multi-Manager Small Cap Opportunities ETF
0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.44%
Ver más
ARK Genomic Revolution ETF
Proporción3.78%
TrueShares Technology, AI & Deep Learning ETF
Proporción2.24%
Global X HealthTech ETF
Proporción1.25%
SPDR FactSet Innovative Technology ETF
Proporción0.97%
WisdomTree BioRevolution Fund
Proporción0.84%
Franklin Exponential Data ETF
Proporción0.81%
Invesco S&P SmallCap Health Care ETF
Proporción0.8%
Franklin Genomic Advancements ETF
Proporción0.63%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.44%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
